This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

BioScrip Inc (BIOS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 1.00M 62.10M 0.00 0.00
Receivables 187.30M 129.10M 225.41M 193.72M
Inventories 34.34M 34.03M 56.74M 66.51M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 236.96M 235.43M 292.47M 276.93M
Property, Plant & Equipment, Gross 84.24M 57.09M 70.70M 59.74M
Accumulated Depreciation & Depletion 42.63M 33.36M 41.26M 35.82M
Property, Plant & Equipment, Net 41.61M 23.72M 29.44M 23.92M
Intangibles 32.22M 17.45M 25.23M 30.10M
Other Non-Current Assets 20.94M 14.97M 5.82M 8.90M
Total Non-Current Assets 699.90M 406.95M 384.63M 387.06M
Liabilities & Shareholder Equity
Total Assets 936.86M 642.38M 677.10M 663.99M
Accounts Payable 71.98M 60.02M 116.14M 103.63M
Short Term Debt 60.26M 953.00K 66.16M 81.35M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 174.31M 108.27M 220.77M 226.79M
Long Term Debt 375.32M 225.43M 227.30M 225.12M
Deferred Income Taxes 15.11M 10.29M 10.30M 9.14M
Other Non-Current Liabilities 17.54M 4.98M 3.46M 2.84M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 407.97M 240.70M 241.05M 237.10M
Total Liabilities 582.28M 348.97M 461.82M 463.88M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 354.58M 293.41M 215.28M 200.10M
Common Par 7.00K 6.00K 6.00K 6.00K
Additional Paid In Capital 519.62M 388.80M 375.52M 368.25M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -154.74M -85.08M -149.79M -157.66M
Treasury Stock -10.31M -10.31M -10.46M -10.50M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 729.90M 518.84M 442.58M 425.22M
Total Equity 354.58M 293.41M 215.28M 200.10M
Total Liabilities & Stock Equity 936.86M 642.38M 677.10M 663.99M
Total Common Shares Outstanding 68.13M 57.03M 55.11M 54.12M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 2.58M 2.58M 2.64M 2.64M
Basic Weighted Shares Outstanding 64.56M 56.24M 54.50M 50.37M
Diluted Weighted Shares Outstanding 64.56M 56.24M 55.15M 50.37M
Number of Employees 2893 2112 2241 2281
Number of Part-Time Employees 1016 827 1168 1194
BIOS News

Analysts Ratings for BIOS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 3 3 3
Moderate Buy 2 2 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BIOS ANALYST REPORT

Brokerage Partners

BIOS Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs